In patients with cancer, platelets are activated by ADP, thrombin, some metalloproteases, and interleukin (IL)-6 produced by tumor cells that induce the expression of adhesion molecules on platelet surface (e.g., P-selectin) increasing their tendency to aggregation [21]. The gene discussed is SELP; the disease is neoplasm.